BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gangar M, Goyal S, Raykar D, Khurana P, Martis AM, Goswami A, Ghoshal I, Patel KV, Nagare Y, Raikar S, Mukherjee A, Cyriac R, Paquin JF, Kulkarni A. Design, synthesis and biological evaluation studies of novel small molecule ENPP1 inhibitors for cancer immunotherapy. Bioorg Chem 2021;119:105549. [PMID: 34929517 DOI: 10.1016/j.bioorg.2021.105549] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Jeong HJ, Lee HL, Kim SJ, Jeong JH, Ji SH, Kim HB, Kang M, Chung HW, Park CS, Choo H, Yoon HJ, Kim NJ, Lee DH, Lee SH, Han SJ. Identification of novel pyrrolopyrimidine and pyrrolopyridine derivatives as potent ENPP1 inhibitors. J Enzyme Inhib Med Chem 2022;37:2434-51. [PMID: 36069240 DOI: 10.1080/14756366.2022.2119566] [Reference Citation Analysis]
2 Goswami A, Deb B, Goyal S, Gosavi A, Mali M, Martis AM, Khurana P, Gangar M, Raykar D, Mohanty A, Kulkarni A. AVA-NP-695 Selectively Inhibits ENPP1 to Activate STING Pathway and Abrogate Tumor Metastasis in 4T1 Breast Cancer Syngeneic Mouse Model. Molecules 2022;27:6721. [PMID: 36235254 DOI: 10.3390/molecules27196721] [Reference Citation Analysis]
3 Song S, Shao Z. From Myricetin to the Discovery of Novel Natural Human ENPP1 Inhibitors: A Virtual Screening, Molecular Docking, Molecular Dynamics Simulation, and MM/GBSA Study. Molecules 2022;27:6175. [DOI: 10.3390/molecules27196175] [Reference Citation Analysis]